139 related articles for article (PubMed ID: 30702149)
1. Crystal structure of archaeal HMG-CoA reductase: insights into structural changes of the C-terminal helix of the class-I enzyme.
Vögeli B; Shima S; Erb TJ; Wagner T
FEBS Lett; 2019 Mar; 593(5):543-553. PubMed ID: 30702149
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis.
Istvan ES; Palnitkar M; Buchanan SK; Deisenhofer J
EMBO J; 2000 Mar; 19(5):819-30. PubMed ID: 10698924
[TBL] [Abstract][Full Text] [Related]
3. The structure of the catalytic portion of human HMG-CoA reductase.
Istvan ES; Deisenhofer J
Biochim Biophys Acta; 2000 Dec; 1529(1-3):9-18. PubMed ID: 11111074
[TBL] [Abstract][Full Text] [Related]
4. Structural mechanism for statin inhibition of HMG-CoA reductase.
Istvan ES; Deisenhofer J
Science; 2001 May; 292(5519):1160-4. PubMed ID: 11349148
[TBL] [Abstract][Full Text] [Related]
5. Substrate-induced closure of the flap domain in the ternary complex structures provides insights into the mechanism of catalysis by 3-hydroxy-3-methylglutaryl-CoA reductase.
Tabernero L; Bochar DA; Rodwell VW; Stauffacher CV
Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7167-71. PubMed ID: 10377386
[TBL] [Abstract][Full Text] [Related]
6. Structural Features and Domain Movements Controlling Substrate Binding and Cofactor Specificity in Class II HMG-CoA Reductase.
Miller BR; Kung Y
Biochemistry; 2018 Feb; 57(5):654-662. PubMed ID: 29224355
[TBL] [Abstract][Full Text] [Related]
7. Structural mechanism for statin inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase.
Istvan ES
Am Heart J; 2002 Dec; 144(6 Suppl):S27-32. PubMed ID: 12486413
[TBL] [Abstract][Full Text] [Related]
8. The 3-hydroxy-3-methylglutaryl coenzyme-A reductases from fungi: a proposal as a therapeutic target and as a study model.
Andrade-Pavón D; Sánchez-Sandoval E; Rosales-Acosta B; Ibarra JA; Tamariz J; Hernández-Rodríguez C; Villa-Tanaca L
Rev Iberoam Micol; 2014; 31(1):81-5. PubMed ID: 24270073
[TBL] [Abstract][Full Text] [Related]
9. New Crystallographic Snapshots of Large Domain Movements in Bacterial 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase.
Ragwan ER; Arai E; Kung Y
Biochemistry; 2018 Oct; 57(39):5715-5725. PubMed ID: 30199631
[TBL] [Abstract][Full Text] [Related]
10. Insight into the mechanism of polyphenols on the activity of HMGR by molecular docking.
Islam B; Sharma C; Adem A; Aburawi E; Ojha S
Drug Des Devel Ther; 2015; 9():4943-51. PubMed ID: 26357462
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an HMG-CoA reductase from Listeria monocytogenes that exhibits dual coenzyme specificity.
Theivagt AE; Amanti EN; Beresford NJ; Tabernero L; Friesen JA
Biochemistry; 2006 Dec; 45(48):14397-406. PubMed ID: 17128979
[TBL] [Abstract][Full Text] [Related]
12. Structural and Functional Characterization of Dynamic Oligomerization in
Peacock RB; Hicks CW; Walker AM; Dewing SM; Lewis KM; Abboud JC; Stewart SWA; Kang C; Watson JM
Biochemistry; 2019 Sep; 58(38):3960-3970. PubMed ID: 31469273
[TBL] [Abstract][Full Text] [Related]
13. On the inhibitor effects of bergamot juice flavonoids binding to the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) enzyme.
Leopoldini M; Malaj N; Toscano M; Sindona G; Russo N
J Agric Food Chem; 2010 Oct; 58(19):10768-73. PubMed ID: 20843083
[TBL] [Abstract][Full Text] [Related]
14. The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases.
Friesen JA; Rodwell VW
Genome Biol; 2004; 5(11):248. PubMed ID: 15535874
[TBL] [Abstract][Full Text] [Related]
15. The increasingly complex mechanism of HMG-CoA reductase.
Haines BE; Wiest O; Stauffacher CV
Acc Chem Res; 2013 Nov; 46(11):2416-26. PubMed ID: 23898905
[TBL] [Abstract][Full Text] [Related]
16. Structure-based rational quest for potential novel inhibitors of human HMG-CoA reductase by combining CoMFA 3D QSAR modeling and virtual screening.
Zhang QY; Wan J; Xu X; Yang GF; Ren YL; Liu JJ; Wang H; Guo Y
J Comb Chem; 2007; 9(1):131-8. PubMed ID: 17206841
[TBL] [Abstract][Full Text] [Related]
17. Exploration of virtual candidates for human HMG-CoA reductase inhibitors using pharmacophore modeling and molecular dynamics simulations.
Son M; Baek A; Sakkiah S; Park C; John S; Lee KW
PLoS One; 2013; 8(12):e83496. PubMed ID: 24386216
[TBL] [Abstract][Full Text] [Related]
18. Computational study of conformational changes in human 3-hydroxy-3-methylglutaryl coenzyme reductase induced by substrate binding.
Costa CHS; Oliveira ARS; Dos Santos AM; da Costa KS; Lima AHLE; Alves CN; Lameira J
J Biomol Struct Dyn; 2019 Oct; 37(16):4374-4383. PubMed ID: 30470158
[TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) gene from Paris fargesii Franch.
Liang Y; Jiang X; Hu Q; Li X; Yin H; Li D; Zhang Y; Liu X
Indian J Biochem Biophys; 2014 Jun; 51(3):201-6. PubMed ID: 25204081
[TBL] [Abstract][Full Text] [Related]
20. Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies.
Dinesh N; Pallerla DS; Kaur PK; Kishore Babu N; Singh S
Microb Pathog; 2014 Jan; 66():14-23. PubMed ID: 24239940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
